— Know what they know.
Not Investment Advice

CHME OTC

China Medicine Corp.
1W: -21.3% 1M: -52.1% 3M: +51.2% YTD: -4.6% 1Y: +2483.3% 3Y: +30900.0% 5Y: +55.0%
$0.03
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 44 · $735074 mcap · 15M float · 0.026% daily turnover · Short 99% of daily vol

Balance Sheet Trends

Total Assets
$67M +49.6% ▲
5Y CAGR: +81.9%
Total Liabilities
$21M +1876.4% ▲
5Y CAGR: +75.5%
Shareholders Equity
$45M +5.2% ▲
5Y CAGR: +85.0%
Cash & Investments
$472K -83.1% ▼
5Y CAGR: +14.1%
Total Debt
$10M +0.0% ▲
Net Debt
$9M +423.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2005FY2006FY2007FY2008FY2009
— Assets —
Cash$2K$371K$6M$3M$472K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2K$371K$6M$3M$472K
Net Receivables$0$7M$14M$20M$22M
Inventory$0$2M$4M$5M$3M
Other Current Assets$0$4M$81K$192K$461K
Total Current Assets$2K$13M$29M$34M$30M
Property, Plant & Equip.$0$1M$1M$4M$12M
Goodwill & Intangibles$0$682$1M$1M$17M
Long-Term Investments$0$0$0$0$8M
Other Non-Current Assets$0$0$678K$6M$0
Total Non-Current Assets$0$1M$3M$11M$37M
Total Assets$2K$15M$33M$45M$67M
— Liabilities —
Accounts Payable$170K$189K$77K$61K$1M
Short-Term Debt$32K$0$0$0$10M
Deferred Revenue$0$0$0$0$3M
Other Current Liabilities-$268K$411K$715K$1M$3M
Total Current Liabilities$32K$600K$863K$1M$14M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$7M
Total Non-Current Liabilities$0$0$0$0$7M
Total Liabilities$32K$600K$863K$1M$21M
— Equity —
Common Stock$103$816$1K$2K$2K
Retained Earnings-$32K$8M$14M$22M$23M
Accumulated OCI$0$757K$4M$4M$4M
Total Stockholders Equity-$30K$13M$31M$43M$45M
Total Liabilities & Equity$2K$15M$33M$45M$67M
— Key Metrics —
Total Debt$32K$0$0$0$10M
Net Debt$30K-$371K-$6M-$3M$9M
Total Investments$0$0$0$0$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms